Millennial fighting rare bone cancer responds to Biden

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
131
Millennial fighting rare bone cancer responds
to Biden vow: Law supported by Trump helped
save my life < >

A millennial who's fighting a rare form of cancer hit back Friday at Joe Biden's claim that his presidency would "cure cancer," and credited legislation passed during President Trump's administration with saving her life.

Natalie Harp, who has battled stage 2 bone cancer for most of her life, said during an appearance on "Fox & Friends" that President Trump's "Right to Try" act allowed her to make a comeback after a nurse's medical mistake in 2015 left her wheelchair-bound and in excruciating pain.

"I'm not dying from cancer any more thanks to President Trump, I'm living with cancer," she said.

President Trump phoned in to "Fox & Friends" on Friday to celebrate his 73rd birthday and called Harp a "young, beautiful woman" who had benefited from the "Right to Try Act."

The measure allows terminally ill patients to access drug treatments that have not yet been fully approved by the Food and Drug Administration.

That's what happened to Natalie Harp, when she ran out of options in 2015.

A nurse accidentally mixed up her IV with a sample of sterile water, which nearly killed her. She was offered opioids, medical marijuana, barbiturates, and even informed on Right to Die policies and voluntarily stopping her consumption of food and water (VSED).

"I'm like 'no, I just want to get better,'" she said. As a California resident, Harp said that her Democratic representatives were offering her rights, but not the ones she wanted.

"ObamaCare made health care about a president rather than a patient," Harp argued.

Biden made headlines earlier this week with the bold claim during a speech in Iowa.

"I promise you if I'm elected president, you're going to see the single most important thing that changes America, we're gonna cure cancer," Biden said.

Harp said that although 2020 hopeful Biden certainly understands the devastation caused by cancer, after losing his son Beau to brain cancer in 2015, he shouldn't use the disease as a "political tool."

Harp failed two rounds of chemotherapy and was rejected from clinical trials, and was faced with having to wait for medical practices to catch up with her disease. When Trump signed "Right to Try" last year, she was permitted to explore experimental treatment opportunities, find new doctors and different medications to improve her life.

"I'm walking. I am healthy. I am living the quality of life that I always wanted to have that it took me four years to find because I wasn't offered it here," she said.

"It took President Trump going to Washington to be able to get that for me."
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 154

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 150

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 84

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 184

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 211

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 83

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 167

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 156

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Australia's Inflation Trends: A Mixed Outlook

Updated Category News Views 437

Insights on Recent Trends in Australian Inflation Recent data on Australian consumer price inflation sheds valuable light on the economy's condition, showing some positive developments. The latest figures reveal that inflation has decreased to a three-year low, largely due to government efforts to lower electricity costs and a fall in petrol prices. Factors Contributing...

Continue Reading
Oatly Group AB to Announce Q1 2025 Earnings and Insights

Updated Category News Views 312

Oatly Group AB Prepares for Q1 2025 Financial Results Oatly Group AB (Nasdaq: OTLY), recognized globally as the leading oat drink manufacturer, is set to unveil its financial performance for the first quarter ending March 31, 2025. This exciting announcement will take place on April 30, 2025, prior to the opening of U.S. markets. Conference Call and Webcast Details The...

Continue Reading
Booking Holdings Set for Q3 2024 Financial Results Release

Updated Category News Views 51

Booking Holdings to Release Third Quarter 2024 Financial Results Booking Holdings (NASDAQ: BKNG) is gearing up for the announcement of its financial results for the third quarter of 2024. This exciting announcement will become available to the public at approximately 4:00 p.m. ET on an upcoming Wednesday. The press release will be accessible on the company's Investor...

Continue Reading
Enhanced Returns and Diversified Portfolio of CGI Investments

Updated Category News Views 187

Overview of Canadian General Investments Canadian General Investments, Limited (CGI) is a prominent investment firm showcasing a resilient performance in a dynamic market environment. The latest updates reveal an impressive net asset value (NAV) per share standing at $76.67 as of August 31, showcasing healthy returns for the year. With a year-to-date NAV return of 11.9%...

Continue Reading
Class Action Lawsuits Impacting Symbotic, PDD, Extreme Networks and Sprinklr

Updated Category News Views 63

Class Action Lawsuits: The New Battlefront for Investors Class action lawsuits are popping off left and right against some heavyweights in the tech space—Symbotic Inc., PDD Holdings Inc., Extreme Networks, and Sprinklr Inc. With the legal wheels turning, it’s crucial for investors to understand what these developments mean for their cash. No one wants to be blindsided...

Continue Reading